Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registry.
Central venous congestion
Haemodynamics
Right heart failure
Transcatheter tricuspid valve repair
Tricuspid regurgitation
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
04 Apr 2024
04 Apr 2024
Historique:
revised:
22
03
2024
received:
04
12
2023
accepted:
28
03
2024
medline:
4
4
2024
pubmed:
4
4
2024
entrez:
4
4
2024
Statut:
aheadofprint
Résumé
While invasively determined congestion holds mechanistic and prognostic significance in acute heart failure (HF), its role in patients with tricuspid regurgitation (TR)-related right- heart failure (HF) undergoing transcatheter tricuspid valve intervention (TTVI) is less well established. A comprehensive understanding of congestion patterns might aid in procedural planning, risk stratification, and the identification of patients who may benefit from adjunctive therapies before undergoing TTVI. The aim of this study was to investigate the role of congestion patterns in patients with severe TR and its implications for TTVI. Within a multicentre, international TTVI registry, 813 patients underwent right heart catheterization (RHC) prior to TTVI and were followed up to 24 months. The median age was 80 (interquartile range 76-83) years and 54% were women. Both mean right atrial pressure (RAP) and pulmonary capillary wedge pressure (PCWP) were associated with 2-year mortality on Cox regression analyses with Youden index-derived cut-offs of 17 mmHg and 19 mmHg, respectively (p < 0.01 for all). However, RAP emerged as an independent predictor of outcomes following multivariable adjustments. Pre-interventionally, 42% of patients were classified as euvolaemic (RAP <17 mmHg, PCWP <19 mmHg), 23% as having left-sided congestion (RAP <17 mmHg, PCWP ≥19 mmHg), 8% as right-sided congestion (RAP ≥17 mmHg, PCWP <19 mmHg), and 27% as bilateral congestion (RAP ≥17 mmHg, PCWP ≥19 mmHg). Patients with right-sided or bilateral congestion had the lowest procedural success rates and shortest survival times. Congestion patterns allowed for discerning specific patient's physiology and specifying prognostic implications of right ventricular to pulmonary artery coupling surrogates. In this large cohort of invasively characterized patients undergoing TTVI, congestion patterns involving right-sided congestion were associated with low procedural success and higher mortality rates after TTVI. Whether pre-interventional reduction of right-sided congestion can improve outcomes after TTVI should be established in dedicated studies.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Else-Kroener-Fresenius-Foundation, Bad Homburg, Germany
Informations de copyright
© 2024 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 2014;7:1185–1194. https://doi.org/10.1016/j.jcmg.2014.07.018
Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 2019;12:433–442. https://doi.org/10.1016/j.jcmg.2018.06.014
Schlotter F, Orban M, Rommel KP, Besler C, von Roeder M, Braun D, et al. Aetiology‐based clinical scenarios predict outcomes of transcatheter edge‐to‐edge tricuspid valve repair of functional tricuspid regurgitation. Eur J Heart Fail 2019;21:1117–1125. https://doi.org/10.1002/ejhf.1547
Aalders M, Kok W. Comparison of hemodynamic factors predicting prognosis in heart failure: A systematic review. J Clin Med 2019;8:1757. https://doi.org/10.3390/jcm8101757
Rommel KP, Besler C, Noack T, Blazek S, von Roeder M, Fengler K, et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc Interv 2019;12:1423–1434. https://doi.org/10.1016/j.jcin.2019.02.042
Nagata R, Harada T, Omote K, Iwano H, Yoshida K, Kato T, et al. Right atrial pressure represents cumulative cardiac burden in heart failure with preserved ejection fraction. ESC Heart Fail 2022;9:1454–1462. https://doi.org/10.1002/ehf2.13853
Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez‐Montfort J, Mahr C, et al. Invasive hemodynamic assessment and classification of in‐hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail 2020;13:e007099. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007099
Stocker TJ, Hertell H, Orban M, Braun D, Rommel KP, Ruf T, et al. Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure. JACC Cardiovasc Interv 2021;14:29–38. https://doi.org/10.1016/j.jcin.2020.09.033
Unterhuber M, Kresoja KP, Besler C, Rommel KP, Orban M, von Roeder M, et al. Cardiac output states in patients with severe functional tricuspid regurgitation: Impact on treatment success and prognosis. Eur J Heart Fail 2021;23:1784–1794. https://doi.org/10.1002/ejhf.2307
Rommel KP, Besler C, Unterhuber M, Kresoja KP, Noack T, Kister T, et al. Stressed blood volume in severe tricuspid regurgitation: Implications for transcatheter treatment. JACC Cardiovasc Interv 2023;16:2245–2258. https://doi.org/10.1016/j.jcin.2023.07.040
Fortmeier V, Lachmann M, Korber MI, Unterhuber M, Schöber AR, Stolz L, et al. Sex‐related differences in clinical characteristics and outcome prediction among patients undergoing transcatheter tricuspid valve intervention. JACC Cardiovasc Interv 2023;16:909–923. https://doi.org/10.1016/j.jcin.2023.01.378
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 2017;18:1342–1343. https://doi.org/10.1093/ehjci/jex139
Lang RM, Badano LP, Mor‐Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–270. https://doi.org/10.1093/ehjci/jev014
Lurz P, Orban M, Besler C, Braun D, Schlotter F, Noack T, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J 2020;41:2785–2795. https://doi.org/10.1093/eurheartj/ehaa138
Borlaug BA, Reddy YNV. The role of the pericardium in heart failure: Implications for pathophysiology and treatment. JACC Heart Fail 2019;7:574–585. https://doi.org/10.1016/j.jchf.2019.03.021
Kresoja KP, Lauten A, Orban M, Rommel KP, Alushi B, Besler C, et al. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Eur J Heart Fail 2020;22:1817–1825. https://doi.org/10.1002/ejhf.1975
Schlotter F, Miura M, Kresoja KP, Alushi B, Alessandrini H, Attinger‐Toller A, et al. Outcomes of transcatheter tricuspid valve intervention by right ventricular function: A multicentre propensity‐matched analysis. EuroIntervention 2021;17:e343–e352. https://doi.org/10.4244/EIJ‐D‐21‐00191
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561–632. https://doi.org/10.1093/eurheartj/ehab395
Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger‐Toller A, Biasco L, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol 2019;74:2998–3008. https://doi.org/10.1016/j.jacc.2019.09.028
Orban M, Rommel KP, Ho EC, Unterhuber M, Pozzoli A, Connelly KA, et al. Transcatheter edge‐to‐edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail 2020;8:265–276. https://doi.org/10.1016/j.jacc.2019.09.028
Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, et al.; TRILUMINATE Pivotal Investigators. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med 2023;388:1833–1842. https://doi.org/10.1056/NEJMoa2300525
Besler C, Orban M, Rommel KP, Braun D, Patel M, Hagl C, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge‐to‐edge repair. JACC Cardiovasc Interv 2018;11:1119–1128. https://doi.org/10.1016/j.jcin.2018.05.002
Kresoja KP, Rommel KP, Lucke C, Unterhuber M, Besler C, von Roeder M, et al. Right ventricular contraction patterns in patients undergoing transcatheter tricuspid valve repair for severe tricuspid regurgitation. JACC Cardiovasc Interv 2021;14:1551–1561. https://doi.org/10.1016/j.jcin.2021.05.005
Stolz L, Weckbach LT, Karam N, Kalbacher D, Praz F, Lurz P, et al. Invasive right ventricular to pulmonary artery coupling in patients undergoing transcatheter edge‐to‐edge tricuspid valve repair. JACC Cardiovasc Imaging 2023;16:564–566. https://doi.org/10.1016/j.jcmg.2022.10.004
Brener MI, Lurz P, Hausleiter J, Rodés‐Cabau J, Fam N, Kodali SK, et al. Right ventricular‐pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair. J Am Coll Cardiol 2022;79:448–461. https://doi.org/10.1016/j.jacc.2021.11.031
Andersen MJ, Nishimura RA, Borlaug BA. The hemodynamic basis of exercise intolerance in tricuspid regurgitation. Circ Heart Fail 2014;7:911–917. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001575
Baratto C, Caravita S, Corbetta G, Soranna D, Zambon A, Dewachter C, et al. Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction. Front Cardiovasc Med 2023;10:1061118. https://doi.org/10.3389/fcvm.2023.1061118
Fudim M, Kaye DM, Borlaug BA, Shah SJ, Rich S, Kapur NK, et al. Venous tone and stressed blood volume in heart failure: JACC review topic of the week. J Am Coll Cardiol 2022;79:1858–1869. https://doi.org/10.1016/j.jacc.2022.02.050